Trinity Biotech plc

Informe acción NasdaqGS:TRIB

Capitalización de mercado: US$17.1m

Trinity Biotech Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

John Gillard

Chief Executive Officer (CEO)

US$863.0k

Compensación total

Porcentaje del salario del CEO52.4%
Permanencia del CEO3.5yrs
Participación del CEOn/a
Permanencia media de la dirección6.1yrs
Promedio de permanencia en la Junta Directiva1.6yrs

Actualizaciones recientes de la dirección

Recent updates

Investors Don't See Light At End Of Trinity Biotech plc's (NASDAQ:TRIB) Tunnel And Push Stock Down 27%

Mar 02
Investors Don't See Light At End Of Trinity Biotech plc's (NASDAQ:TRIB) Tunnel And Push Stock Down 27%

Trinity Biotech plc's (NASDAQ:TRIB) Shares Bounce 31% But Its Business Still Trails The Industry

Dec 18
Trinity Biotech plc's (NASDAQ:TRIB) Shares Bounce 31% But Its Business Still Trails The Industry

A Look At The Fair Value Of Trinity Biotech plc (NASDAQ:TRIB)

Sep 12
A Look At The Fair Value Of Trinity Biotech plc (NASDAQ:TRIB)

Should You Investigate Trinity Biotech plc (NASDAQ:TRIB) At US$0.80?

Aug 08
Should You Investigate Trinity Biotech plc (NASDAQ:TRIB) At US$0.80?

Insufficient Growth At Trinity Biotech plc (NASDAQ:TRIB) Hampers Share Price

Jun 09
Insufficient Growth At Trinity Biotech plc (NASDAQ:TRIB) Hampers Share Price

Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)

Apr 23
Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)

This Broker Just Slashed Their Trinity Biotech plc (NASDAQ:TRIB) Earnings Forecasts

Apr 23
This Broker Just Slashed Their Trinity Biotech plc (NASDAQ:TRIB) Earnings Forecasts

Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Mar 01
Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Trinity Biotech appoints former GE executive Aris Kekedjian as CEO

Oct 03

At US$1.22, Is Trinity Biotech plc (NASDAQ:TRIB) Worth Looking At Closely?

Sep 01
At US$1.22, Is Trinity Biotech plc (NASDAQ:TRIB) Worth Looking At Closely?

Trinity Biotech GAAP EPADS of -50c, revenue of $18.78M misses by $1.22M

Jun 30

Returns Are Gaining Momentum At Trinity Biotech (NASDAQ:TRIB)

Jun 14
Returns Are Gaining Momentum At Trinity Biotech (NASDAQ:TRIB)

Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Mar 23
Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Is Trinity Biotech plc (NASDAQ:TRIB) Popular Amongst Insiders?

Feb 25
Is Trinity Biotech plc (NASDAQ:TRIB) Popular Amongst Insiders?

Trinity Biotech plc (NASDAQ:TRIB) Could Be Less Than A Year Away From Profitability

Feb 02
Trinity Biotech plc (NASDAQ:TRIB) Could Be Less Than A Year Away From Profitability

A Treatise On Trinity Biotech

Jan 13

Did You Miss Trinity Biotech's (NASDAQ:TRIB) Impressive 241% Share Price Gain?

Jan 05
Did You Miss Trinity Biotech's (NASDAQ:TRIB) Impressive 241% Share Price Gain?

What Do The Returns At Trinity Biotech (NASDAQ:TRIB) Mean Going Forward?

Dec 10
What Do The Returns At Trinity Biotech (NASDAQ:TRIB) Mean Going Forward?

Trinity Biotech (NASDAQ:TRIB) Takes On Some Risk With Its Use Of Debt

Nov 19
Trinity Biotech (NASDAQ:TRIB) Takes On Some Risk With Its Use Of Debt

Trinity Biotech EPS beats by $0.22, beats on revenue

Nov 17

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de John Gillard en comparación con los beneficios de Trinity Biotech?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

-US$37m

Sep 30 2023n/an/a

-US$39m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$34m

Dec 31 2022US$863kUS$452k

-US$44m

Sep 30 2022n/an/a

-US$32m

Jun 30 2022n/an/a

-US$22m

Mar 31 2022n/an/a

-US$13m

Dec 31 2021US$593kUS$346k

-US$2m

Sep 30 2021n/an/a

-US$8m

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$2m

Dec 31 2020US$312kUS$52k

-US$6m

Compensación vs. Mercado: La compensación total ($USD863.00K) de John está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD668.06K).

Compensación vs. Ingresos: La compensación de John ha aumentado mientras la empresa no es rentable.


CEO

John Gillard (42 yo)

3.5yrs

Permanencia

US$863,000

Compensación

Mr. John Gillard is President & CEO of Trinity Biotech plc since December 19, 2023 and served as Chief Financial Officer since November 17, 2020 until December 19, 2023. He serves as Executive Director at...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
John Gillard
President3.5yrsUS$863.00ksin datos
Ronan O'Caoimh
Founder & Directorno dataUS$340.00k5.14%
$ 876.2k
James Walsh
Executive Director of Business Development & Executive Directorno dataUS$20.00k0.74%
$ 125.6k
Des Fitzgerald
Interim Chief Financial Officerless than a yearsin datossin datos
Simon Dunne
Chief Accounting Officer16.5yrssin datos0%
$ 0
Gary Keating
Chief Technology Officerno datasin datossin datos
Eibhlin Kelly
Chief Information Officer8.7yrssin datossin datos
Colm Molloy
Group Director of Human Resources & Cultureno datasin datossin datos

6.1yrs

Permanencia media

50yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de TRIB es experimentado (6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
John Gillard
President3.5yrsUS$863.00ksin datos
Ronan O'Caoimh
Founder & Director1.6yrsUS$340.00k5.14%
$ 876.2k
James Walsh
Executive Director of Business Development & Executive Director17.3yrsUS$20.00k0.74%
$ 125.6k
Andrew Omidvar
Directorless than a yearsin datossin datos
Thomas Lindsay
Independent Non-Executive Director1.6yrssin datossin datos

1.6yrs

Permanencia media

65.5yo

Promedio de edad

Junta con experiencia: La junta directiva de TRIB no se considera experimentada (1.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.